Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Takeda identifies benzazepine derivatives for treatment of obesity

Jan. 3, 2012

Toray divulges new inhibitors of 11-beta-HSD1

Jan. 2, 2012

Astellas Pharma presents new drug for treatment of transplant rejection

Jan. 2, 2012

Findings presented from two phase III trials of Lu-AA-21004 in GAD

Jan. 2, 2012

Study evaluates repeated daily oxytocin as a therapy for anxiety

Dec. 30, 2011

Dengue virus vaccine assessed in healthy volunteers

Dec. 30, 2011

Phase III BTOG2 trial assesses combination therapies for advanced lung cancer

Dec. 30, 2011

U.K. study uncovers new putative biomarker of pulmonary arterial hypertension

Dec. 29, 2011

Clinical studies assess prasugrel in sickle cell disease

Dec. 29, 2011

BiTE antibody shows promise to treat diffuse large B-cell lymphoma

Dec. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...